Trexquant Investment’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.1M Buy
7,000
+6,500
+1,300% +$7.67M 0.05% 536
2026
Q2
$600K Buy
+500
New +$511K ﹤0.01% 1595

Other funds holding LLY

Trexquant Investment's LLY Position: Q3 2026 in Review

Trexquant Investment reduced its Eli Lilly (LLY) stake by 32% in Q3 2026, selling an estimated $34M and leaving 62,059 shares worth $71.8M. The position accounts for 0.42% of the portfolio, ranked #20.

Trexquant Investment first reported a position in LLY in Q4 2014 and has held it in 24 quarters since. The position peaked at $109M in Q2 2026. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Trexquant Investment held 62,059 shares of Eli Lilly worth $71.8M as of Q3 2026.
  • Trexquant Investment sold 28,791 Eli Lilly shares in Q3 2026, an estimated $34M.
  • Eli Lilly made up 0.42% of Trexquant Investment's portfolio in Q3 2026, its #20 holding.
  • Trexquant Investment first reported a position in Eli Lilly in Q4 2014 and has held it in 24 quarters since.
  • Trexquant Investment's Eli Lilly position peaked at $109M in Q2 2026.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Trexquant Investment's 13F filing for Q3 2026, filed 16 Nov 2026.